 Boston Scientific Corp. received a subpoena on July 11 from the U.S. Attorney for the District of New Jersey concerning Bridgepoint Medical Inc., a cardiology products company it acquired in October 2012.. The subpoena, disclosed in Boston Scientific's quarterly report filed with the Securities and Exchange Commission, seeks information on sales of CrossBoss and Stingray products, related educational and training activities and the acquisition.